BR0214322A - ácidos 2-aril-propiÈnicos e composições farmacêuticas contendo os mesmos - Google Patents

ácidos 2-aril-propiÈnicos e composições farmacêuticas contendo os mesmos

Info

Publication number
BR0214322A
BR0214322A BR0214322-4A BR0214322A BR0214322A BR 0214322 A BR0214322 A BR 0214322A BR 0214322 A BR0214322 A BR 0214322A BR 0214322 A BR0214322 A BR 0214322A
Authority
BR
Brazil
Prior art keywords
acids
pharmaceutical compositions
compositions containing
treatment
aryl
Prior art date
Application number
BR0214322-4A
Other languages
English (en)
Other versions
BRPI0214322B1 (pt
Inventor
Marcello Allegretti
Maria Candida Cesta
Francesco Colotta
Riccardo Bertini
Cinzia Bizzarri
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of BR0214322A publication Critical patent/BR0214322A/pt
Publication of BRPI0214322B1 publication Critical patent/BRPI0214322B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/67—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C07C59/135—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/04—Monocyclic monocarboxylic acids
    • C07C63/06—Benzoic acid
    • C07C63/08—Salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"áCIDOS 2-ARIL-PROPIÈNICOS E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS". A presente invenção refere-se aos ácidos (R) e (S) 2-aril-propiónicos e composições farmacêuticas que contêm os mesmos que são úteis na inibição de ativação quimiotática de neutrófilos (leucócitos de PMN) induzida pela interação de Interleucina-8 (IL-8) com os receptores de membrana CXCR1 e CXCR2. Os ácidos são usados para prevenção e tratamento de patologias derivando da ativação. Especificamente, os enanciómeros (R) dos ditos ácidos não possuem atividade de inibição de ciclo-oxigenase e são especificamente úteis no tratamento de patologias dependentes de neutrófilos, tais como, psoríase, colite ulcerativa, melanoma, doença pulmonar crónica obstrutiva (COPD), pênfigo bolhoso, artrite reumatóide, fibrose idiopática, glomerulonefrite e na prevenção e tratamento de danos causados por isquemia e reperfusão.
BRPI0214322A 2001-11-20 2002-11-19 ácidos 2-aril-propiônicos, seu uso e seus processos de preparação, bem como composições farmacêuticas contendo os mesmos BRPI0214322B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI002434A ITMI20012434A1 (it) 2001-11-20 2001-11-20 Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
PCT/EP2002/012939 WO2003043625A1 (en) 2001-11-20 2002-11-19 2-aryl-propionic acids and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
BR0214322A true BR0214322A (pt) 2004-11-03
BRPI0214322B1 BRPI0214322B1 (pt) 2016-07-12

Family

ID=27638512

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0214322A BRPI0214322B1 (pt) 2001-11-20 2002-11-19 ácidos 2-aril-propiônicos, seu uso e seus processos de preparação, bem como composições farmacêuticas contendo os mesmos

Country Status (24)

Country Link
US (1) US8063242B2 (pt)
EP (2) EP2229942B1 (pt)
JP (1) JP4549674B2 (pt)
KR (2) KR101060064B1 (pt)
CN (1) CN100376242C (pt)
AT (1) ATE447401T1 (pt)
AU (1) AU2002352052B2 (pt)
BR (1) BRPI0214322B1 (pt)
CA (1) CA2465375C (pt)
DE (1) DE60234272D1 (pt)
DK (2) DK2229942T3 (pt)
ES (2) ES2393589T3 (pt)
HU (1) HU229077B1 (pt)
IL (2) IL161767A0 (pt)
IT (1) ITMI20012434A1 (pt)
MX (1) MXPA04004744A (pt)
NO (1) NO334286B1 (pt)
NZ (1) NZ532705A (pt)
PL (1) PL209745B1 (pt)
PT (2) PT2229942E (pt)
RU (1) RU2317075C2 (pt)
SI (1) SI1455773T1 (pt)
WO (1) WO2003043625A1 (pt)
ZA (1) ZA200403436B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010395A1 (it) 2001-02-27 2002-08-27 Dompe Spa Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
EP1457485A1 (en) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonic acids, their derivatives and pharmaceutical compositions containing them
PT1776336E (pt) * 2004-03-23 2009-12-18 Dompe Spa Derivados de ácido 2-fenilpropiónico e composições farmacêuticas que os contêm
RS53007B (sr) * 2006-05-18 2014-04-30 Dompe' S.P.A. (2r)-2-[(4-sulfonil)aminofenil]propanamidi i farmaceutske kompozicije koje ih sadrže
WO2009018447A2 (en) * 2007-07-31 2009-02-05 New York University Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
CN101959429B (zh) * 2008-01-08 2014-09-10 阿克塞利亚制药公司 抗微生物肽系统的激动剂
EP2166006A1 (en) 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
CN101416961B (zh) * 2008-11-21 2012-02-15 合肥金科生物医药科技有限公司 一种苯丙酸类药物光学异构体及其制药用途
MX2011011757A (es) 2009-05-04 2012-01-25 Prometic Biosciences Inc Compuestos aromaticos substituidos y usos farmaceuticos.
EA035494B1 (ru) * 2010-10-27 2020-06-25 Прометик Фарма Смт Лимитед Способ и применение композиции для ингибирования миграции клеток опухоли и образования метастазов
DE102011119821A1 (de) 2011-12-01 2013-06-06 Bundesdruckerei Gmbh Elektrooptisches Sicherheitselement
TWI689489B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
EP3174851A1 (en) * 2014-07-31 2017-06-07 GlaxoSmithKline Intellectual Property Management Limited Use of cxcr2 antagonists for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (cipn)
CN108794319B (zh) * 2018-07-10 2021-01-15 艾希尔（深圳）药物研发有限公司 一种布洛芬杂质a的制备方法
CN110038000A (zh) * 2019-04-10 2019-07-23 徐州医科大学 Dat在制备预防或治疗肠炎及相关疾病或症状的药物中的应用
CN112778167A (zh) * 2019-11-01 2021-05-11 邵阳学院 一种快速制备n-苯磺酰基氨基酸酯类化合物的方法
ES2960292T3 (es) * 2020-10-05 2024-03-04 Basf Se 1-alkoxietil-3-isobutilbenceno y 1-carboxietil-3-isobutilbenceno como ingredientes aromáticos

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621255A (pt) *
NL137301C (pt) * 1966-03-30
US3629320A (en) * 1969-04-09 1971-12-21 Geigy Chem Corp 2-(4-halo- and 4-trifluoromethylphenylsulfonamido)phenylacetic acids and esters thereof
GB1308327A (en) * 1970-04-14 1973-02-21 Reckitt & Colmann Prod Ltd Phenylalkane derivatives and processes for the preparation thereof
ES415446A1 (es) * 1973-06-01 1976-02-16 Gallardo Antonio Sa Un procedimiento para la obtencion de derivados de acidos m-benzoilfenil alcanoicos.
JPS5111748A (en) * 1974-07-16 1976-01-30 Taisho Pharmaceutical Co Ltd Suchirubenjudotaino seizoho
JPS582934B2 (ja) * 1974-07-29 1983-01-19 ニツシンセイフン カブシキガイシヤ ２−（置換アリ−ル）−プロピオン酸の製法
FR2316211A1 (fr) * 1975-07-04 1977-01-28 Dick Pierre Nouveau mode d'acces a des derives d'acides phenyl carboxyliques
JPS5283822A (en) 1976-01-01 1977-07-13 Ikeda Mohando Co Naphthylaminopheny acetic acid derivatives and salts thereof*
JPS537640A (en) * 1976-07-09 1978-01-24 Teikoku Hormone Mfg Co Ltd Synthesis of diphenylamine derivatives
US4465855A (en) * 1978-05-23 1984-08-14 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt Process for the preparation of arylacetic acid derivatives
JPS58194814A (ja) 1982-05-11 1983-11-12 Nippon Shinyaku Co Ltd 免疫調節作用を有する薬剤
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
IT1230752B (it) 1989-02-17 1991-10-29 Boehringer Biochemia Srl Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.
US4940813A (en) * 1989-03-31 1990-07-10 Merck & Co., Inc. Resolution of a carboxylic acid
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
US5981592A (en) * 1995-03-13 1999-11-09 Loma Linda University Medical Center Method and composition for treating cystic fibrosis
US5862341A (en) 1996-07-03 1999-01-19 Net Manage, Inc. Screen identification method
IT1283649B1 (it) 1996-08-02 1998-04-23 Dompe Spa Procedimento per la preparazione di acidi 2-aril-propionici e 2-aril-acetici a partire da aril-olefine
US6214881B1 (en) 1996-08-21 2001-04-10 Smithkline Beecham Corporation IL-8 receptor antagonists
KR100220645B1 (ko) 1997-07-04 1999-09-15 구광시 벤젠유도체의 제조방법
IT1298214B1 (it) 1998-01-28 1999-12-20 Dompe Spa Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche.
NZ509238A (en) 1998-07-27 2003-07-25 Emisphere Tech Inc Pulmonary delivery of active agents the carrier containing acylated or sulfonated amino acids
IT1303249B1 (it) 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
DE19907895A1 (de) * 1999-02-24 2000-11-16 Paz Arzneimittelentwicklung Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen bei Mensch und Tier, welche durch die Hemmung der Aktivierung von NF-kB therapeutisch beeinflußt werden können
AUPP975699A0 (en) * 1999-04-14 1999-05-06 Futurepump Ltd Vacuum apparatus
IT1317826B1 (it) 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.

Also Published As

Publication number Publication date
HK1075014A1 (zh) 2005-12-02
IL161767A0 (en) 2005-11-20
IL216230A0 (en) 2011-12-29
PL209745B1 (pl) 2011-10-31
EP2229942A1 (en) 2010-09-22
DE60234272D1 (de) 2009-12-17
RU2004118605A (ru) 2005-05-10
US8063242B2 (en) 2011-11-22
IL216230A (en) 2014-12-31
JP4549674B2 (ja) 2010-09-22
RU2317075C2 (ru) 2008-02-20
SI1455773T1 (sl) 2010-01-29
NO20042564L (no) 2004-06-18
CA2465375A1 (en) 2003-05-30
EP1455773A1 (en) 2004-09-15
ITMI20012434A1 (it) 2003-05-20
BRPI0214322B1 (pt) 2016-07-12
HUP0600336A2 (en) 2006-08-28
NZ532705A (en) 2007-05-31
ES2333943T3 (es) 2010-03-03
CN1612729A (zh) 2005-05-04
US20050038119A1 (en) 2005-02-17
HU229077B1 (hu) 2013-07-29
DK2229942T3 (da) 2012-11-26
WO2003043625A1 (en) 2003-05-30
AU2002352052A1 (en) 2003-06-10
CA2465375C (en) 2012-07-31
ZA200403436B (en) 2005-07-27
KR101015003B1 (ko) 2011-02-16
EP1455773B1 (en) 2009-11-04
PL370585A1 (pl) 2005-05-30
NO334286B1 (no) 2014-01-27
KR20100099342A (ko) 2010-09-10
DK1455773T3 (da) 2010-03-22
EP2229942B1 (en) 2012-08-29
JP2005514357A (ja) 2005-05-19
MXPA04004744A (es) 2004-09-03
PT1455773E (pt) 2010-02-04
PT2229942E (pt) 2012-12-04
ES2393589T3 (es) 2012-12-26
ATE447401T1 (de) 2009-11-15
KR20050044526A (ko) 2005-05-12
KR101060064B1 (ko) 2011-08-29
AU2002352052B2 (en) 2008-09-04
CN100376242C (zh) 2008-03-26

Similar Documents

Publication Publication Date Title
CY1109687T1 (el) Παραγωγα 2-φαινυλπροπιονικου οξεος και φαρμακευτικες συνθεσεις που τα περιεχουν
NO20054672L (no) Sulfonsyrer, derivater derav og farmasoytiske prepater omfattende slike forbindelser
Powers et al. Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4
BR0116379A (pt) Antagonistas de receptor y5 de neuropeptìdeo y de uréia de heteroarila
Jadhav et al. Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV
BR0108152A (pt) Amidas úteis na inibição de quimiotaxia de neutrófilos induzida por il-8
MXPA04004744A (es) Acidos 2-aril-propionicos y composiciones farmaceuticas que contienen a los mismo.
Zhang et al. Structure-based optimization of N-substituted oseltamivir derivatives as potent anti-influenza A virus agents with significantly improved potency against oseltamivir-resistant N1-H274Y variant
MA29256B1 (fr) Composes pharmaceutiques
NO20072153L (no) (Bifenyl)-karboksylsyrer og derivater derav
TNSN07349A1 (fr) Derives de n-(n-sulfonylaminomethyl) cyclopropanecarboxamide utiles pour le traitement de la douleur
BR0207664A (pt) Èmega-aminoalquilamidas de ácidos r-2-aril-propiÈnico como inibidores da quimiotaxia de células polimorfonucleadas e mononucleadas
ECSP055910A (es) Nuevos acidos carboxilicos y sus esteres, medicamentos que contienen estos compuestos y procedimientos para su preparacion
AR046313A1 (es) Compuesto de 2-cianopirrolidincarboxamida, un metodo para su obtencion y su empleo en composiciones farmaceuticas y en medicamentos con actividad inhibitoria de la dipeptidil peptidasa-iv (dpp-iv).
BR0314611A (pt) Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
NO20084517L (no) Substituerte bifenylkarboksylsyrer og derivater derav
BRPI0517621A (pt) sais hidroxibenzoato de compostos de metanicotina
Li et al. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors
BRPI0517456A (pt) sìntese assimétrica de dihidrobenzofuranos substituìdos
WO2004069782A3 (en) 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
EA200001152A1 (ru) СУКЦИНАМИДНЫЕ ИНГИБИТОРЫ ИНТЕРЛЕЙКИН - 1b - КОНВЕРТИРУЮЩЕГО ФЕРМЕНТА
BRPI0817824B8 (pt) derivados de (r)-4-(heteroaril) feniletila e composições farmacêuticas contendo os mesmos
BR0306824A (pt) Derivados de ácidos alfa-feniltiocarboxìlico e alfa-fenilóxi-carboxìlico úteis para o tratamento de doenças respondendo à ativação de pparalfa
EA200100807A1 (ru) Производные алкинилсодержащих гидроксамовых кислот и их применение в качестве ингибиторов tace
ATE449082T1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl) amine mit aktivität am 5-ht-rezeptor

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: DOMPE PHA.R.MA S.P.A. (IT)

Free format text: TRANSFERIDO DE: DOMPE S.P.A.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 31/192, A61K 31/195, A61K 31/196, A61K 31/255, A61P 1/04, A61P 11/00, A61P 13/12, A61P 17/00, A61P 17/06, A61P 19/02, A61P 29/00, A61P 35/00, A61P 43/00, A61P 9/10, C07C 211/56, C07C 229/42, C07C 307/02, C07C 307/10,C07C 309/00, C07C 309/65, C07C 309/67, C07C 309/73, C07C 311/00, C07C 311/08, C07C 311/09, C07C 311/21, C07C 317/44, C07C 57/30, C07C 57/32, C07C 57/38, C07C 57/42, C07C 57/46, C07C 57/50, C07C 57/58, C07C 59/135, C07C 59/48, C07C 59/68

Ipc: A61K 31/192 (2011.01), C07C 57/42 (2011.01), C07C

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: DOMPE' S.P.A. (IT)

Free format text: TRANSFERIDO POR FUSAO DE: DOMPE PHA.R.MA S.P.A.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B25A Requested transfer of rights approved

Owner name: DOMPE FARMACEUTICI S.P.A (IT)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/07/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2604 DE 01-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.